LIST OF TABLES
TABLE 1 HPAPI GLOBAL MARKET REVENUE, BY REGION
(2015-2023) ($MN) 26
TABLE 2 HPAPI GLOBAL MARKET REVENUE, BY CUSTOMER BASE
(2015-2023) ($MN) 72
TABLE 3 INNOVATIVE HPAPI GLOBAL MARKET REVENUE, BY REGION
(2015-2023) ($MN) 75
TABLE 4 GENERIC HPAPI GLOBAL MARKET REVENUE, BY REGION
(2015-2023) ($MN) 76
TABLE 5 HPAPI GLOBAL MARKET REVENUE, BY BUSINESS TYPE
(2015-2023) ($MN) 77
TABLE 6 CAPTIVE HPAPI GLOBAL MARKET REVENUE, BY REGION
(2015-2023) ($MN) 79
TABLE 7 MERCHANT HPAPI GLOBAL MARKET REVENUE, BY REGION
(2015-2023) ($MN) 81
TABLE 8 HPAPI GLOBAL MARKET REVENUE, BY MOLECULE TYPE
(2015-2023) ($MN) 82
TABLE 9 SYNTHETIC HPAPI GLOBAL MARKET REVENUE, BY REGION
(2015-2023) ($MN) 84
TABLE 10 BIOTECH HPAPI GLOBAL MARKET REVENUE, BY REGION
(2015-2023) ($MN) 86
TABLE 11 HPAPI GLOBAL MARKET REVENUE, BY APPLICATIONS,
(2015-2023) ($MN) 88
TABLE 12 CENTRAL NERVOUS SYSTEMS HPAPI GLOBAL MARKET REVENUE,
BY REGION, (2015-2023) ($MN) 91
TABLE 13 ONCOLOGY HPAPI GLOBAL MARKET REVENUE,BY REGION,
(2015-2023) $MN) 93
TABLE 14 HORMONAL DISORDERS HPAPI GLOBAL MARKET REVENUE,BY REGION, (2015-2023) ($MN) 94
TABLE 15 GLAUCOMA HPAPI GLOBAL MARKET REVENUE,BY REGION,
(2015-2023) ($MN) 96
TABLE 16 INFECTIOUS DISEASES HPAPI GLOBAL MARKET REVENUE,BY REGION, (2015-2023) ($MN) 97
TABLE 17 METABOLIC DISORDERS HPAPI GLOBAL MARKET REVENUE,BY REGION, (2015-2023) ($MN) 98
TABLE 18 CARDIOVASCULAR HPAPI GLOBAL MARKET REVENUE,BY REGION,
(2015-2023) ($MN) 100
TABLE 19 INFLAMMATION HPAPI GLOBAL MARKET REVENUE,BY REGION,
(2015-2023) ($MN) 101
TABLE 20 OTHER APPLICATIONS HPAPI GLOBAL MARKET REVENUE,BY REGION,
(2015-2023) ($MN) 102
TABLE 21 NORTH AMERICAN HPAPI MARKET REVENUE, BY CUSTOMER BASE,
(2015-2023) ($MN) 105
TABLE 22 NORTH AMERICAN HPAPI MARKET REVENUE, BY BUSINESS TYPE,
(2015-2023) ($MN) 106
TABLE 23 NORTH AMERICAN HPAPI MARKET REVENUE,BY MOLECULE TYPE,
(2015-2023) ($MN) 107
TABLE 24 NORTH AMERICAN HPAPI MARKET REVENUE,BY APPLICATIONS ,
(2015-2023) ($MN) 108
TABLE 25 EUROPEAN HPAPI MARKET REVENUE, BY CUSTOMER BASE,
(2015-2023) ($MN) 117
TABLE 26 EUROPEAN HPAPI MARKET REVENUE, BY BUSINESS TYPE,
(2015-2023) ($MN) 118
TABLE 27 EUROPEAN HPAPI MARKET REVENUE,BY MOLECULE TYPE,
(2015-2023) ($MN) 119
TABLE 28 EUROPEAN HPAPI MARKET REVENUE,BY APPLICATIONS,
(2015-2023) ($MN) 120
TABLE 29 ASIA PACIFIC HPAPI MARKET REVENUE, BY CUSTOMER BASE,
(2015-2023) ($MN) 136
TABLE 30 ASIA PACIFIC HPAPI MARKET REVENUE, BY BUSINESS TYPE,
(2015-2023) ($MN) 137
TABLE 31 ASIA PACIFIC HPAPI MARKET REVENUE,BY MOLECULE TYPE,
(2015-2023) ($MN) 138
TABLE 32 ASIA PACIFIC HPAPI MARKET REVENUE,BY APPLICATIONS
(2015-2023) ($MN) 139
TABLE 33 ROW HPAPI MARKET REVENUE, BY CUSTOMER BASE,
(2015-2023) ($MN) 152
TABLE 34 ROW HPAPI MARKET REVENUE, BY BUSINESS TYPE,
(2015-2023) ($MN) 153
TABLE 35 ROW HPAPI MARKET REVENUE,BY MOLECULE TYPE,
(2015-2023) ($MN) 154
TABLE 36 ROW HPAPI MARKET REVENUE,BY APPLICATIONS (2015-2023) ($MN) 155
TABLE 37 EXPANSIONS, AGREEMENTS, ACQUISTIONS, APPROVALSAND OTHER DEVELOPMENTS (2015-2017) 166
TABLE 38 ALKERMES PLC: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN) 173
TABLE 39 ALKERMES PLC: TOTAL REVENUE, BY SEGMENTS, (2015-2017) ($MN) 174
TABLE 40 ALKERMES PLC: TOTAL REVENUE, BY SUB-SEGMENTS, (2015-2017) ($MN) 175
TABLE 41 ALKERMES PLC: TOTAL REVENUE, BY GEOGRAPHY, (2015-2017) ($MN) 176
TABLE 42 CAMBREX CORPORATION: TOTAL REVENUE AND R&D EXPENSES,
(2015-2017) ($MN) 180
TABLE 43 CAMBREX CORPORATION: TOTAL REVENUE, BY GEOGRAPHY,
(2015-2017) ($MN) 181
TABLE 44 DISHMAN GROUP: TOTAL REVENUE AND R&D EXPENSES,
(2014-2016) ($MN) 185
TABLE 45 DISHMAN GROUP: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN) 185
TABLE 46 DR. REDDY’S LABORATORIES: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN) 189
TABLE 47 DR. REDDY’S LABORATORIES: TOTAL REVENUE, BY SEGMENTS,
(2014-2016) ($MN) 190
TABLE 48 DR. REDDY’S LABORATORIES: TOTAL REVENUE, BY GEOGRAPHY,
(2014-2016) ($MN) 191
TABLE 49 LONZA GROUP: TOTAL REVENUE AND R&D EXPENSES (2015-2017) ($MN) 194
TABLE 50 LONZA GROUP: TOTAL REVENUE, BY SEGMENT, (2015-2017) ($MN) 195
TABLE 51 LONZA GROUP: TOTAL REVENUE, BY GEOGRAPHY (2015-2017) ($MN) 196
TABLE 52 PATHEON N.V.: TOTAL REVENUE AND R&D EXPENSES (2015-2017) ($MN) 203
TABLE 53 PATHEON N.V.: TOTAL REVENUE, BY SEGMENT, (2015-2017) ($MN) 204
TABLE 54 PATHEON N.V.: TOTAL REVENUE, BY GEOGRAPHY (2015-2017) ($MN) 205
TABLE 55 PFIZER INC: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN) 210
TABLE 56 PFIZER INC: TOTAL REVENUE, BY SEGMENTS, (2015-2017) ($MN) 210
TABLE 57 PFIZER INC: TOTAL REVENUE, BY GEOGRAPHY, (2015-2017) ($MN) 211
TABLE 58 MERCK KGAA: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN) 216
TABLE 59 MERCK KGAA: TOTAL REVENUE, BY SEGMENTS, (2015-2017) ($MN) 217
TABLE 60 MERCK KGAA: TOTAL REVENUE, BY GEOGRAPHY, (2015-2017) ($MN) 218
TABLE 61 TEVA PHARMACEUTICAL INDUSTRIES: TOTAL REVENUE AND
R&D EXPENSES, (2015-2017) ($MN) 221
TABLE 62 TEVA PHARMACEUTICAL INDUSTRIES: TOTAL REVENUE,
BY SEGMENTS, (2015-2017) ($MN) 222
TABLE 63 TEVA PHARMACEUTICAL INDUSTRIES: TOTAL REVENUE,
BY GEOGRAPHY, (2015-2017) ($MN) 222
LIST OF FIGURES
FIGURE 1 HPAPI GLOBAL MARKET SHARE AND REVENUE, BY REGION (2015-2023) 27
FIGURE 2 RESEARCH METHODOLOGY: HPAPI GLOBAL MARKET 33
FIGURE 3 HPAPI GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH 34
FIGURE 4 HPAPI GLOBAL MARKET: FORECASTING MODEL 35
FIGURE 5 HPAPI GLOBAL MARKET: MARKET BREAKDOWN & DATA TRIANGULATION 36
FIGURE 6 HPAPI GLOBAL MARKET SEGMENTATION 43
FIGURE 7 MARKET DYNAMICS 44
FIGURE 8 HPAPI GLOBAL MARKET: PORTER’S ANALYSIS 52
FIGURE 9 HPAPI GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS 2016 (%) 59
FIGURE 10 HPAPI MARKET: SUPPLY CHAIN ANALYSIS 61
FIGURE 11 HPAPI GLOBAL MARKET SHARE, BY CUSTOMER BASE (2016 V/S 2023) (%) 73
FIGURE 12 HPAPI GLOBAL MARKET REVENUE, BY BUSINESS TYPE
(2016 V/S 2023) ($ MN) 78
FIGURE 13 HPAPI GLOBAL MARKET REVENUE, BY MOLECULE TYPE
(2016 V/S 2023) ($ MN) 83
FIGURE 14 HPAPI GLOBAL MARKET SHARE, BY APPLICATIONS (2016) (%) 89
FIGURE 15 HPAPI GLOBAL MARKET SHARE AND REVENUE,
BY REGION (2016-2023) ($MN) 104
FIGURE 16 NORTH AMERICAN HPAPI MARKET REVENUE, BY CUSTOMER BASE,
BUSINESS TYPE & MOLECULE TYPE (2016 V/S 2023) ($MN) 109
FIGURE 17 NORTH AMERICAN HPAPI MARKET SHARE, BY APPLICATIONS
(2016 V/S 2023) (%) 110
FIGURE 18 UNITED STATES HPAPI MARKET REVENUE, BY CUSTOMER BASE,
BUSINESS TYPE & MOLECULE TYPE (2016 V/S 2023) ($MN) 113
FIGURE 19 UNITED STATES HPAPI MARKET SHARE, BY APPLICATIONS
(2016 V/S 2023) (%) 114
FIGURE 20 OTHER NORTH AMERICAN REGIONS HPAPI MARKET REVENUE, BY CUSTOMER
BASE, BUSINESS TYPE & MOLECULE TYPE (2016 V/S 2023) ($MN) 115
FIGURE 21 OTHER NORTH AMERICAN REGIONS HPAPI MARKET SHARE, BY APPLICATIONS (2016 V/S 2023) (%) 116
FIGURE 22 EUROPEAN HPAPI MARKET REVENUE, BY CUSTOMER BASE, BUSINESS
TYPE & MOLECULE TYPE (2016 V/S 2023) ($MN) 121
FIGURE 23 EUROPEAN HPAPI MARKET SHARE, BY APPLICATIONS (2016 V/S 2023) ($MN) 122
FIGURE 24 SWITZERLAND HPAPI MARKET REVENUE, BY CUSTOMER BASE, BUSINESS
TYPE & MOLECULE TYPE (2016 V/S 2023) ($MN) 124
FIGURE 25 SWITZERLAND HPAPI MARKET SHARE, BY APPLICATIONS
(2016 V/S 2023) (%) 125
FIGURE 26 GERMANY HPAPI MARKET REVENUE, BY CUSTOMER BASE,BUSINESS TYPE & MOLECULE TYPE (2016 V/S 2023) ($MN) 127
FIGURE 27 GERMANY HPAPI MARKET SHARE, BY APPLICATIONS (2016 V/S 2023) (%) 128
FIGURE 28 U.K. HPAPI MARKET REVENUE, BY CUSTOMER BASE, BUSINESS TYPE
& MOLECULE TYPE (2016 V/S 2023) ($MN) 130
FIGURE 29 U.K. HPAPI MARKET SHARE, BY APPLICATIONS (2016 V/S 2023) (%) 131
FIGURE 30 OTHER EUROPEAN REGIONS HPAPI MARKET REVENUE, BY CUSTOMER BASE, BUSINESS TYPE & MOLECULE TYPE (2016 V/S 2023) ($MN) 134
FIGURE 31 OTHER EUROPEAN REGIONS HPAPI MARKET SHARE, BY APPLICATIONS
(2016 V/S 2023) (%) 135
FIGURE 32 ASIA PACIFIC HPAPI MARKET REVENUE, BY CUSTOMER BASE, BUSINESS
TYPE & MOLECULE TYPE (2016 V/S 2023) ($MN) 140
FIGURE 33 ASIA PACIFIC HPAPI MARKET SHARE,BY APPLICATIONS
(2016 V/S 2023) (%) 141
FIGURE 34 INDIA HPAPI MARKET REVENUE, BY CUSTOMER BASE,BUSINESS TYPE
& MOLECULE TYPE (2016 V/S 2023) ($MN) 143
FIGURE 35 INDIA HPAPI MARKET SHARE, BY APPLICATIONS (2016 V/S 2023) (%) 144
FIGURE 36 CHINA HPAPI MARKET REVENUE, BY CUSTOMER BASE,BUSINESS TYPE
& MOLECULE TYPE (2016 V/S 2023) ($MN) 146
FIGURE 37 CHINA HPAPI MARKET SHARE, BY APPLICATIONS (2016 V/S 2023) (%) 147
FIGURE 38 JAPAN HPAPI MARKET REVENUE, BY CUSTOMER BASE,BUSINESS TYPE
& MOLECULE TYPE (2016 V/S 2023) ($MN) 148
FIGURE 39 JAPAN HPAPI MARKET SHARE, BY APPLICATIONS (2016 V/S 2023) (%) 149
FIGURE 40 OTHER ASIA PACIFIC REGIONS HPAPI MARKET REVENUE, BY CUSTOMER
BASE, BUSINESS TYPE & MOLECULE TYPE (2016 V/S 2023) (%) 150
FIGURE 41 OTHER ASIA PACIFIC REGIONS HPAPI SHARE, BY APPLICATIONS
(2016 V/S 2023) (%) 151
FIGURE 42 ROW HPAPI MARKET REVENUE, BY CUSTOMER BASE,BUSINESS TYPE
& MOLECULE TYPE (2016 V/S 2023) ($MN) 156
FIGURE 43 ROW HPAPI MARKET SHARE BY APPLICATIONS (2016 V/S 2023) (%) 157
FIGURE 44 BRAZIL HPAPI MARKET REVENUE, BY CUSTOMER BASE, BUSINESS TYPE
& MOLECULE TYPE (2016 V/S 2023) ($MN) 158
FIGURE 45 BRAZIL HPAPI MARKET SHARE, BY APPLICATIONS (2016 V/S 2023) (%) 159
FIGURE 46 REST OF LATIN AMERICA HPAPI MARKET REVENUE, BY CUSTOMER BASE, BUSINESS TYPE & MOLECULE TYPE (2016 V/S 2023) ($MN) 160
FIGURE 47 REST OF LATIN AMERICA HPAPI MARKET REVENUE, BY APPLICATIONS
(2016 V/S 2023) (%) 161
FIGURE 48 MIDDLE EAST & OTHERS HPAPI MARKET REVENUE, BY CUSTOMER BASE,
BUSINESS TYPE & MOLECULE TYPE (2016 V/S 2023) ($MN) 162
FIGURE 49 MIDDLE EAST & OTHERS HPAPI MARKET SHARE, BY APPLICATIONS
(2016 V/S 2023) (%) 163
FIGURE 50 KEY GROWTH STRATEGIES, (2015 – 2017) 165
FIGURE 51 SWOT: ALKERMES PLC 178
FIGURE 52 SWOT: CAMBREX CORPORATION 183
FIGURE 53 SWOT: DISHMAN GROUP 187
FIGURE 54 SWOT: DR. REDDY’S LABORATORIES 192
FIGURE 55 SWOT: LONZA GROUP 198
FIGURE 56 SWOT: NOVASEP 201
FIGURE 57 SWOT: PATHEON N.V. 208
FIGURE 58 SWOT: PFIZER INC. 214
FIGURE 59 SWOT: MERCK KGAA 220
FIGURE 60 SWOT: TEVA PHARMACEUTICAL INDUSTRIES 225
*If Applicable.